Filing Details

Accession Number:
0001209191-17-055251
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-03 17:15:42
Reporting Period:
2017-10-02
Accepted Time:
2017-10-03 17:15:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124140 Exact Sciences Corp EXAS Services-Commercial Physical & Biological Research (8731) 204782291
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216274 Peter Graham Lidgard C/O Exact Sciences Corp.
441 Charmany Drive
Madison WI 53719
Chief Science Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-02 35,250 $13.96 366,519 No 4 M Direct
Common Stock Disposition 2017-10-02 81,025 $47.16 285,494 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-10-02 35,250 $13.96 35,250 $13.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,750 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 12,014 Indirect Held in 401(K) Account
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.57 to $47.93, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
  3. This option vests in four equal annual installments beginning on February 24, 2015.